FHIR IG analytics| Package | hl7.fhir.uv.ebm |
| Resource Type | Evidence |
| Id | Evidence-267233.json |
| FHIR Version | R6 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: Evidence 267233
version: 9; Last updated: 2025-12-11 20:35:21+0000; Language: en
Profile: NonComparativeEvidence
url: https://fevir.net/resources/Evidence/267233
identifier: FEvIR Object Identifier/267233, FEvIR Linking Identifier/NCT03421379-primaryOutcomeMeasure-0--OG001
name: NCT03421379_primaryOutcomeMeasure_0_OG001
title: Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia at Pre-dose up to 30 minutes post each glucagon administration for Glucagon Hydrochloride Solution in NCT03421379
citeAs:
Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia at Pre-dose up to 30 minutes post each glucagon administration for Glucagon Hydrochloride Solution in NCT03421379 [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267233. Revised 2025-12-11. Available at: https://fevir.net/resources/Evidence/267233. Computable resource at: https://fevir.net/resources/Evidence/267233#json.
status: Active
author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter:
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
description:
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
variableDefinition
description:
Glucagon Hydrochloride Solution
note: ,
Outcome Measure Population Description: All randomized participant who completed both treatment visits and had evaluable treatment success data.
Outcome Measure Denominator Units: Participants
variableRole: Population
observed: A single dose of 1 mg glucagon hydrochloride solution was administered IM (Identifier: ClinicalTrials.gov Outcome Measurement Group Id/OG001)
variableDefinition
variableRole: Outcome
statistic
statisticType: Number (see protocol for details)
quantity: 100 percentage of participants
SampleSizes
KnownDataCount 68
{
"resourceType": "Evidence",
"id": "267233",
"meta": {
"versionId": "9",
"lastUpdated": "2025-12-11T20:35:21.032Z",
"profile": [
"http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"
]
},
"language": "en",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "https://fevir.net/resources/Evidence/267233",
"identifier": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0203",
"code": "ACSN",
"display": "Accession ID"
}
],
"text": "FEvIR Object Identifier"
},
"system": "https://fevir.net/FOI",
"value": "267233",
"assigner": {
"display": "Computable Publishing LLC"
}
},
{
"type": {
"text": "FEvIR Linking Identifier"
},
"system": "https://fevir.net/FLI",
"value": "NCT03421379-primaryOutcomeMeasure-0--OG001",
"assigner": {
"display": "Computable Publishing LLC"
}
}
],
"name": "NCT03421379_primaryOutcomeMeasure_0_OG001",
"title": "Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia at Pre-dose up to 30 minutes post each glucagon administration for Glucagon Hydrochloride Solution in NCT03421379",
"citeAs": "Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia at Pre-dose up to 30 minutes post each glucagon administration for Glucagon Hydrochloride Solution in NCT03421379 [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267233. Revised 2025-12-11. Available at: https://fevir.net/resources/Evidence/267233. Computable resource at: https://fevir.net/resources/Evidence/267233#json.",
"status": "active",
"author": [
{
"name": "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"
}
],
"publisher": "Computable Publishing LLC",
"contact": [
{
"telecom": [
{
"system": "email",
"value": "support@computablepublishing.com"
}
]
}
],
"copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"description": "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
"variableDefinition": [
{
"description": "Glucagon Hydrochloride Solution",
"note": [
{
"text": "Outcome Measure Population Description: All randomized participant who completed both treatment visits and had evaluable treatment success data."
},
{
"text": "Outcome Measure Denominator Units: Participants"
}
],
"variableRole": "population",
"observed": {
"identifier": {
"type": {
"text": "ClinicalTrials.gov Outcome Measurement Group Id"
},
"value": "OG001"
},
"display": "A single dose of 1 mg glucagon hydrochloride solution was administered IM"
}
},
{
"variableRole": "outcome",
"observed": {
"reference": "EvidenceVariable/267226",
"type": "EvidenceVariable",
"identifier": {
"type": {
"text": "FEvIR Linking Identifier"
},
"system": "https://fevir.net/FLI",
"value": "NCT03421379-primaryOutcome-0",
"assigner": {
"display": "Computable Publishing LLC"
}
},
"display": "Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia at Pre-dose up to 30 minutes post each glucagon administration - (NCT03421379)"
}
}
],
"statistic": [
{
"statisticType": {
"text": "Number (see protocol for details)"
},
"quantity": {
"value": 100,
"unit": "percentage of participants"
},
"sampleSize": {
"knownDataCount": 68
}
}
]
}